Kala Pharmaceuticals (NASDAQ:KALA) specializes in developing innovative eye care treatments, particularly focusing on therapies for diseases with significant unmet medical needs. The company works on a range of projects, from early research to advanced clinical trials, aiming to bring groundbreaking solutions to patients suffering from eye conditions worldwide. Key objectives include advancing its pipeline of drug candidates through rigorous testing, securing regulatory approvals, and ultimately improving patient outcomes. With a strong commitment to eye health, Kala Pharmaceuticals is dedicated to making strides in ophthalmic treatment and care.